CD74 and non-small cell lung carcinoma: found a higher incidence of CNS metastasis in patients with NSCLC having CD74‐ROS1 fusion compared to non‐CD74‐ROS1 fusion cases (p = 0.020), suggesting that the type of fusion partner is associated with CNS metastasis.